Rami S. Komrokji MD

Rami S. Komrokji, MD, is Vice Chair of the Department of Malignant Hematology and Head of the Leukemia and Myelodysplastic Syndrome (MDS) Section at Moffitt Cancer Center. He is also a Senior Member of the Malignant Hematology and Experimental Therapeutics Program at Moffitt Cancer Center as well as Professor of Medicine and Oncologic Sciences at the University of South Florida in Tampa, Florida.

Dr. Komrokji received his medical degree from Jordan University School of Medicine in Amman, Jordan. He then completed an internship and residency in internal medicine at Case Western Reserve University/St. Vincent Charity Medical Center in Cleveland, Ohio, followed by a fellowship in hematology/oncology and hematopoietic stem cell transplantation at Strong Memorial Hospital at the University of Rochester in New York.

Dr. Komrokji’s clinical interests include MDS, acute myeloid leukemias, and myeloproliferative neoplasms. His research interests are in Phase I and II clinical trials, as well as outcome research for hematologic malignancies. Dr. Komrokji is an expert on myeloid neoplasms, and he has led several clinical trials and lectured worldwide on this topic. His work led to the US Food and Drug Administration (FDA) approval of luspatercept for myelodysplastic syndromes and pacritinib for myelofibrosis.

To date, Dr. Komrokji has authored or co-authored more than 330 peer-reviewed manuscripts, 20 book chapters, and 1,000 abstracts on hematologic malignancies. He previously served as a member of the MDS Panel of the National Comprehensive Cancer Network (NCCN) and on the editorial board of the Journal of Clinical Oncology (JCO). He is currently a member of the steering committee for the National Heart, Lung, and Blood Institute (NHLBI)’s National MDS Natural History study, and is on the board of directors for the Aplastic Anemia & MDS International Foundation. He is a peer reviewer for several medical journals including Blood, the Journal of Clinical Oncology, and Leukemia. He is regularly invited to speak at national and international meetings and has won several awards in recognition of his work.